Literature DB >> 24599415

Clinical features and underlying causes of cerebral venous thrombosis in Japanese patients.

Akihiro Shindo1, Hideo Wada, Hidehiro Ishikawa, Ai Ito, Masaru Asahi, Yuichiro Ii, Makoto Ikejiri, Hidekazu Tomimoto.   

Abstract

The clinical symptoms, causative factors, and prognosis in Japanese patients with cerebral venous thrombosis have not been adequately characterized. The present study describes these features in patients in Japan. Twenty-two patients with cerebral venous thrombosis were retrospectively identified. Diagnosis was confirmed by either digital subtraction angiography, magnetic resonance venography, or contrast-enhanced computed tomography. Demographic data and clinical and radiological features were recorded and analyzed for each patient. Prognosis was evaluated by the modified Rankin scale (mRS) at the time of hospital discharge. The most frequent symptom of cerebral venous thrombosis was headache (59.1 %). Causative factors included congenital thrombophilia (31.8 %), acquired thrombophilia (27.3 %), and iron-deficiency anemia (13.6 %). Of seven patients with congenital thrombophilia, four had mutations in the protein S gene, two had mutations in the protein C gene, and one had mutations in the antithrombin gene. All patients were alive at discharge from hospital. Nineteen of the 22 patients (86.4 %) recovered completely or exhibited only mild residual symptoms (mRS 0-2). However, three patients (13.6 %) had a poor prognosis (mRS 3-5). Cerebral venous thrombosis in Japanese patients is frequently associated with congenital thrombophilia and protein S gene mutation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24599415     DOI: 10.1007/s12185-014-1550-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  30 in total

Review 1.  Cerebral venous thrombosis: an update.

Authors:  Marie-Germaine Bousser; José M Ferro
Journal:  Lancet Neurol       Date:  2007-02       Impact factor: 44.182

2.  A novel protein S gene mutation combined with protein S Tokushima mutation in a patient with superior sagittal sinus thrombosis.

Authors:  Akihiro Shindo; Makoto Ikejiri; Yuichiro Ii; Kaname Nakatani; Hideo Wada; Tsutomu Nobori; Hidekazu Tomimoto
Journal:  J Neurol       Date:  2011-06-07       Impact factor: 4.849

3.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

4.  Causes and predictors of death in cerebral venous thrombosis.

Authors:  Patrícia Canhão; José M Ferro; Arne G Lindgren; Marie-Germaine Bousser; Jan Stam; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2005-07-07       Impact factor: 7.914

5.  Frequent association of thrombophilia in cerebral venous sinus thrombosis.

Authors:  Makoto Ikejiri; Akihiro Shindo; Yuichiro Ii; Hidekazu Tomimoto; Norikazu Yamada; Takeshi Matsumoto; Yasunori Abe; Kaname Nakatani; Tsutomu Nobori; Hideo Wada
Journal:  Int J Hematol       Date:  2012-03       Impact factor: 2.490

6.  Cerebral vein and dural sinus thrombosis in elderly patients.

Authors:  José M Ferro; Patrícia Canhão; Marie-Germaine Bousser; Jan Stam; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2005-08-11       Impact factor: 7.914

7.  Cerebral venous thrombosis associated with iron deficiency anemia.

Authors:  Toshiyasu Ogata; Masahiro Kamouchi; Takanari Kitazono; Junya Kuroda; Hiroaki Ooboshi; Tadahisa Shono; Takato Morioka; Setsuro Ibayashi; Tomio Sasaki; Mitsuo Iida
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 Nov-Dec       Impact factor: 2.136

8.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

9.  Diffusion-weighted magnetic resonance imaging of dural sinus thrombosis.

Authors:  T Yoshikawa; O Abe; K Tsuchiya; T Okubo; K Tobe; T Masumoto; N Hayashi; H Mori; H Yamada; S Aoki; K Ohtomo
Journal:  Neuroradiology       Date:  2002-04-25       Impact factor: 2.804

10.  Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems.

Authors:  Thomas Bombeli; Adila Basic; Joerg Fehr
Journal:  Am J Hematol       Date:  2002-06       Impact factor: 10.047

View more
  3 in total

1.  Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with fondaparinux.

Authors:  Makoto Ikejiri; Hideo Wada; Toshio Yamaguchi; Shinichi Miyazaki; Masahiro Hasegawa; Hiroki Wakabayashi; Kunihiro Asanuma; Akane Sakaguchi; Takeshi Matsumoto; Kohshi Ohishi; Naoki Fujimoto; Norikazu Yamada; Masaaki Ito; Naoyuki Katayama; Akihiro Sudo
Journal:  Int J Hematol       Date:  2016-02-27       Impact factor: 2.490

2.  High frequency of decreased antithrombin level in pregnant women with thrombosis.

Authors:  Yuki Kamimoto; Hideo Wada; Makoto Ikejiri; Kaname Nakatani; Takashi Sugiyama; Kazuhiro Osato; Nao Murabayashi; Norikazu Yamada; Takeshi Matsumoto; Kohshi Ohishi; Hidehiro Ishikawa; Hidekazu Tomimoto; Masaaki Ito; Tomoaki Ikeda
Journal:  Int J Hematol       Date:  2015-07-02       Impact factor: 2.490

Review 3.  Seizure in cerebral venous and sinus thrombosis.

Authors:  Jafar Mehvari Habibabadi; Mohammad Saadatnia; Nasim Tabrizi
Journal:  Epilepsia Open       Date:  2018-06-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.